Natco Pharma Limited — Board Meeting, 23-07-2025: Outcome of Board Meeting

NATCO Pharma's board approved a major strategic move to expand its global footprint. The company will acquire a 35.75% stake in South African pharma firm Adcock Ingram Holdings for approximately ₹2,000 crore. This aims to boost NATCO's presence in South Africa and offer a gateway to the African continent. Concurrently, NATCO plans to set up a new wholly-owned subsidiary in South Africa with an investment of up to ₹2,100 crore. Additionally, the board decided to liquidate its subsidiary, Time Cap Overseas, to streamline operations and reduce costs. This strategic rejig focuses on growth and efficiency.